Qube Research & Technologies (QRT)
MDLN icon

Qube Research & Technologies (QRT)’s Medline Inc MDLN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,057,071
Closed -$47M – 4240
2026
Q1 		$47M Buy
+1,057,071
New +$46.7M 0.05% 452

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lone Pine Capital
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MDLN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 1,057,071 shares — an estimated $47M sold.

Qube Research & Technologies (QRT) first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $47M in Q1 2026. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,057,071 Medline Inc shares in Q2 2026, an estimated $47M.
  • Qube Research & Technologies (QRT) first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Medline Inc position peaked at $47M in Q1 2026.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.